Trademark Overview
On Tuesday, July 8, 2025, a trademark application was filed for SYREMIS with the United States Patent and Trademark Office. The USPTO has given the SYREMIS trademark a serial number of 99271619. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 8, 2025. This trademark is owned by Syremis Therapeutics Ltd.. The SYREMIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of psychiatry and Central Nervous System disorders and diseases, cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, anti-inflammatory, cholesterol, smoking cessation, tissue and skin repair preparations, pain, fever, angina, liver illnesses, heart illnesses; Vitamins; Mineral supplements; Nutritional supplements; Body lubricants for medical use; Medicinal creams for skin care; Gels for dermatological use
Pharmaceutical research services; Scientific and technological services, namely, research and consulting in the field of product development in the field of pharmaceuticals; Scientific and technological services, namely, research and consulting in the field of design and product development in the field of pharmaceuticals; Industrial research in the field of pharmaceuticals; Design and development of intelligence (AI) software for use in the field of pharmaceuticals; Design and development of software for machine learning; Product design and development in the field of pharmaceuticals; Industrial design services; Drug discovery services; Development of pharmaceutical preparations and medicines; Research and development services in the field of pharmaceutical preparations
